Breakthrough research shows hope for reversing damage in neurological disease
Ohio State Wexner Medical Center - October 26, 2020 | Read full media release
Research led by investigators at The Ohio State University Wexner Medical Center provides new hope for recovery from degenerative neurological diseases — such as ALS and multiple sclerosis — as well from as damage caused by traumatic brain and spine injuries and stroke. Dr. Benjamin Segal and Dr. Andrew Sas are quoted.
Wellness Wednesday: CENTAUR Clinical Trial Offers New Hope For ALS Patients
WOSU/NPR - September 23, 2020 | Read full article
Dr. Adam Quick explains results of the new CENTAUR clinical trial for patients with ALS. The Ohio State University Wexner Medical Center participated in the national clinical trial with 7 patients. The Ice Bucket Challenge for ALS helped to fund this research.
Do Nootropics ('Smart Drugs') Actually Work?
HowStuffWorks - September 23, 2020 | Read full article
Nootropics sound like some sort of scary, illegal subset of pharmaceuticals, but chances are you've had one variety or another any time you've popped a can of soda, sipped your daily Starbucks or eaten something made with cocoa. Dr. Kiran Rajneesh is quoted.
Is ‘Sexsomnia’ Really A Thing?
Glamour - September 22, 2020 | Read full article
But for those with sexsomnia, a condition where people carry out sexual behaviors while they snooze, these interruptions can be way more X-rated. Yes, this is a real thing. Dr. Jesse Mindel is quoted.
Women With Longer Periods of Fertility Have Higher Risk of Dementia, Says Study
Yahoo! - September 17, 2020 | Read full article
Women who have longer periods of fertility have a higher risk of dementia late in life, according to a new study. Among women with a longer period of being fertile — namely, 38 years or more — 24 percent of them developed dementia after the age of 85, compared with 16 percent of women with a shorter reproductive period of 32.6 years or less, according to EurekAlert. Dr. Rawan Tarawneh is quoted.
With Limited Treatment Options, Physicians Often Misclassify SPMS As RRMS
Healio - September 12, 2020 | Read full article
Patients with secondary progressive MS on disease-modifying treatments often are clinically misclassified as having relapsing-remitting MS, most likely because they are not reassigned categorically until after conversion has occurred. These findings call into question the use of time to secondary progressive MS (SPMS) conversion as an outcome measure in comparative effectiveness studies that use real-world data, according to the findings presented at MSVirtual2020. Dr. Benjamin Segal is quoted.
Greater Ozone Exposure, Genetic Factors Increase Risk For Pediatric MS
Healio - September 12, 2020 | Read full article
Ozone levels and DRB1 alleles represent independent factors that correlate with risk for pediatric MS, according to findings presented at MSVirtual2020. Dr. Benjamin Segal is quoted.
Can Tau Predict Early MS Disability?
MedPage Today- September 12, 2020 | Read full article
Tau predicted early disability and worse prognosis in multiple sclerosis (MS) patients independently of age, a longitudinal prospective study showed. Findings were reported at MSVirtual 2020, the joint ACTRIMS-ECTRIMS meeting. Dr. Benjamin Segal is quoted.
Ohioan’s Online Alzheimer’s Support Group Spreads Hope Worldwide
Columbus Dispatch - September 14, 2020 | Read full article
Rick Phelps didn’t want to talk about cures, the latest drug down the road or some conspiracy theory about cognition. He wanted support: for caregivers, advocates, but most importantly, for patients. And with a click, Memory People was born. Dr. Douglas Scharre is quoted.
CIRM Funded Trial for Parkinson’s Treats First Patient
The Stem Cellar - September 14, 2020 | Read full article
Brain Neurotherapy Bio, Inc. (BNB) is pleased to announce the treatment of the first patient in its Parkinson’s gene therapy study. The CIRM-funded study, led by Dr. Krystof Bankiewicz, is one of the 64 clinical trials funded by the California state agency to date. Dr. Sandra Kostyk is quoted.
ALS Clinical Trial At Ohio State Called ‘Milestone’ In Slowing Disease
Columbus Dispatch - September 07, 2020 | Read full article
Ohio State University’s Wexner Medical Center participated in a clinical trial that was shown to slow down the progression of ALS, also known as Lou Gehrig’s disease. Dr. Adam Quick is quoted.
Wexner Medical Center Performs Gene Therapy Brain Infusion For Parkinson’s Disease
Ohio State Wexner Medical Center - September 03, 2020 | Read full media release
For the first time ever, a team of neurologists and neurosurgeons at The Ohio State University Wexner Medical Center and The Ohio State College of Medicine has performed a novel gene therapy brain infusion to treat a patient with Parkinson’s disease. Dr. James “Brad” Elder, Dr. Sandra Kostyk and Dr. Krystof Bankiewicz are quoted.
Subgroups Predict Adjuvant Chemoradiotherapy Benefits In Low-Grade Glioma
MD Edge - August 21, 2020 | Read full article
Adjuvant chemoradiotherapy beat radiotherapy alone for treatment of certain patients with World Health Organization (WHO)–defined low-grade glioma (LGG), according to researchers. Erica Bell is quoted.
Emilia Clarke Works to End Stigma Around Brain Injury
Brain & Life - August/September 2020 | Read full article
Shortly before the final season premiered in 2019, Emilia Clarke revealed the source of the strength it took to play such a strong character in Game of Thrones in an article she wrote for the New Yorker: surviving two potentially fatal brain aneurysms during Game of Thrones' early years. Dr. Vivien Lee is quoted.
Multiple Sclerosis Diagnosis: 7 Things to Ask Your Doctor About This Disease
SELF - August 03, 2020 | Read full article
Scared. Anxious. Numb. Angry. It’s understandable to go through a range of emotions when you receive a multiple sclerosis diagnosis. Even if you have a general idea of what multiple sclerosis is and what it entails, you'll probably have some questions once the initial shock wears off. Dr. Benjamin Segal is quoted.
Dementia Symptoms: The ‘Inappropriate’ Sign You Have It
Daily Express - July 07, 2020 | Read full article
Frontotemporal dementia has one known risk factor: genetics. Research published in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association suggests exercise can reduce the risk, even in those that carry the genetic mutation. Dr. Rawan Tarawneh is quoted.
4 Mental Exercises to Keep Your Brain Sharp
U.S. News & World Report - July 03, 2020 | Read full article
No matter how hard we try to slow or stop its movement, time marches inevitably on. As it does, our bodies and their abilities change, too. For some people that means certain changes that can alter how we interact with and perceive the world around us. Dr. Douglas Scharre is quoted.
Ohio Considered A Major Model Of Collaboration In Alzheimer’s Research
Sidney Daily News - July 06, 2020 | Read full article
Ohio is emerging as a major model of collaboration in the area of Alzheimer’s research as the state’s population living with Alzheimer’s grows. Today, 220,000 Ohioans age 65 and older live with Alzheimer’s disease. By 2025, that number is expected to climb to 250,000. Dr. Douglas Scharre is quoted.